EP1009345A4 - TREATMENT OF SKIN AGING AND SKIN Wounds BY MEANS OF CELL MIGRATION ACTIVE SUBSTANCES - Google Patents

TREATMENT OF SKIN AGING AND SKIN Wounds BY MEANS OF CELL MIGRATION ACTIVE SUBSTANCES

Info

Publication number
EP1009345A4
EP1009345A4 EP98934222A EP98934222A EP1009345A4 EP 1009345 A4 EP1009345 A4 EP 1009345A4 EP 98934222 A EP98934222 A EP 98934222A EP 98934222 A EP98934222 A EP 98934222A EP 1009345 A4 EP1009345 A4 EP 1009345A4
Authority
EP
European Patent Office
Prior art keywords
cell migration
skin aging
wound treatment
migration agents
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98934222A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1009345A1 (en
Inventor
Jin Song
John Koch
Marilyn Squier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NATERRA INTERNATIONAL, INC.
Original Assignee
TIME BLOCK Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIME BLOCK Inc filed Critical TIME BLOCK Inc
Publication of EP1009345A1 publication Critical patent/EP1009345A1/en
Publication of EP1009345A4 publication Critical patent/EP1009345A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP98934222A 1997-06-30 1998-06-30 TREATMENT OF SKIN AGING AND SKIN Wounds BY MEANS OF CELL MIGRATION ACTIVE SUBSTANCES Withdrawn EP1009345A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88477997A 1997-06-30 1997-06-30
US884779 1997-06-30
PCT/US1998/013675 WO1999000079A1 (en) 1997-06-30 1998-06-30 Skin aging and wound treatment using cell migration agents

Publications (2)

Publication Number Publication Date
EP1009345A1 EP1009345A1 (en) 2000-06-21
EP1009345A4 true EP1009345A4 (en) 2002-03-13

Family

ID=25385375

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98934222A Withdrawn EP1009345A4 (en) 1997-06-30 1998-06-30 TREATMENT OF SKIN AGING AND SKIN Wounds BY MEANS OF CELL MIGRATION ACTIVE SUBSTANCES

Country Status (4)

Country Link
EP (1) EP1009345A4 (ja)
JP (1) JP2002504933A (ja)
AU (1) AU8379798A (ja)
WO (1) WO1999000079A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMO20060339A1 (it) * 2006-10-23 2008-04-24 Clelia Barini Metodo cosmetico di tonificazione del derma
FR2929115B1 (fr) * 2008-03-31 2010-06-04 Exsymol Sa Utilisation cosmetique de composes conjugues d'auxines indoliques.
FR2984122B1 (fr) * 2011-12-16 2014-08-01 Syntivia Composition cosmetique pour stimuler les fonctions cellulaires anti-vieillissement de la peau
EP4167943A1 (en) * 2020-06-19 2023-04-26 Unilever IP Holdings B.V. Use of indole compounds for treating signs of skin aging
WO2021254754A1 (en) * 2020-06-19 2021-12-23 Unilever Ip Holdings B.V. Use of indole compounds for treating signs of skin aging

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1269573A (fr) * 1959-06-09 1961-08-18 Produits de beauté à base d'auxines
US3271394A (en) * 1964-12-31 1966-09-06 Merck & Co Inc Alpha-indolyl-3-acetic acid esters
FR2597339A1 (fr) * 1986-04-16 1987-10-23 Bounan Michel Trois substances a activite antitumorale preparees par dilutions successives d'hormones vegetales de croissance.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847283A (en) * 1983-01-10 1989-07-11 Harendza Harinxma Alfred J Ointment and method for treating skin lesions due to herpes virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1269573A (fr) * 1959-06-09 1961-08-18 Produits de beauté à base d'auxines
US3271394A (en) * 1964-12-31 1966-09-06 Merck & Co Inc Alpha-indolyl-3-acetic acid esters
FR2597339A1 (fr) * 1986-04-16 1987-10-23 Bounan Michel Trois substances a activite antitumorale preparees par dilutions successives d'hormones vegetales de croissance.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9900079A1 *

Also Published As

Publication number Publication date
AU8379798A (en) 1999-01-19
EP1009345A1 (en) 2000-06-21
WO1999000079A1 (en) 1999-01-07
JP2002504933A (ja) 2002-02-12

Similar Documents

Publication Publication Date Title
GB2346809B (en) Heel care device and method
EP1011746A4 (en) IMPROVED ELECTRODES AND METHOD FOR THEIR USE
GB2334444B (en) Hair treatment composition and method of manufacturing the composition
GB9902320D0 (en) Anodizing electrolyte and its use
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
ZA969217B (en) Skin care preparation and method
PL335157A1 (en) Method of improving salubrity condition of scalp hair
GB9817618D0 (en) Hair treatment device and method
HU9801511D0 (en) Human semaphorin-l (h-sema-l) and corresponding semaphorine in other species
EP0789551A4 (en) AGENTS AND METHODS USED TO PERMANENT THE HAIR
EP1009345A4 (en) TREATMENT OF SKIN AGING AND SKIN Wounds BY MEANS OF CELL MIGRATION ACTIVE SUBSTANCES
GB9704349D0 (en) Levobupivacaine and its use
PL324929A1 (en) Cosmetic method of treating and preventing the symptoms of skin ageing
AU125616S (en) Hair treatment applicator
GB9413869D0 (en) Hair anchoring device
GB9704370D0 (en) Levobupivacaine and its use
GB9712869D0 (en) Hair treatment
GB9726203D0 (en) Hair treatment applicator
GB9720566D0 (en) Hair treatment device and method
GB9718062D0 (en) Hair treatment device and method
GB9405622D0 (en) Skin care method and composition
GB9405579D0 (en) Skin care method and composition
GB9405639D0 (en) Skin care method and composition
GB9601199D0 (en) Electrochemical treatment of mixtures
PL315609A1 (en) Skin care method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH FR LI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SQUIER, MARILYN

Inventor name: KOCH, JOHN

Inventor name: SONG, JIN

A4 Supplementary search report drawn up and despatched

Effective date: 20020125

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH FR LI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61F 13/00 A, 7A 61K 31/405 B, 7A 61K 31/40 B, 7A 61K 7/48 B

17Q First examination report despatched

Effective date: 20020619

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NATERRA INTERNATIONAL, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041130